[Cytotoxicity of amyloid fibrils of X-protein]

Biofizika
|November 30, 2006
PubMed

Insights

Tetracycline disassembles X-protein amyloid fibrils and protects polymorphonuclear leukocytes from cell death. This demonstrates tetracycline

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Context:

  • Amyloid fibrils are known to induce cell death.
  • Tetracycline inhibits amyloid fibril formation and disassembles pre-formed fibrils.
  • Sarcomeric cytoskeletal proteins, including titin family members (X-, C-, and H-proteins), can form amyloid fibrils in vitro.

Purpose:

  • To investigate the cytotoxic effects of X-protein amyloids on polymorphonuclear leukocytes.
  • To evaluate the efficacy of tetracycline in disaggregating X-protein amyloid fibrils and mitigating their cytotoxic effects.
  • To explore the potential of this model system for assessing anti-amyloidosis drug effectiveness.

Summary:

  • The viability of polymorphonuclear leukocytes exposed to X-protein amyloids was found to be dependent on both amyloid concentration and incubation time.
  • Tetracycline effectively disaggregated X-protein amyloid fibrils.
  • Tetracycline treatment eliminated the cytotoxic effect of X-protein amyloids, with no observed toxicity and even an increase in cell viability.

Impact:

  • This study highlights tetracycline's potential in combating amyloid cytotoxicity.
  • The findings suggest a novel approach for evaluating drugs aimed at preventing or treating amyloidosis.
  • Demonstrates the therapeutic potential of targeting amyloid structures with existing antibiotics.